Elsevier

Neurobiology of Disease

Volume 8, Issue 5, October 2001, Pages 847-865
Neurobiology of Disease

Regular Article
Gene Expression Profiling in Postmortem Rett Syndrome Brain: Differential Gene Expression and Patient Classification

https://doi.org/10.1006/nbdi.2001.0428Get rights and content

Abstract

The identification of mutations in the transcriptional repressor methyl-CpG-binding protein 2 (MECP2) gene in Rett Syndrome (RTT) suggests that an inappropriate release of transcriptional silencing may give rise to RTT neuropathology. Despite this progress, the molecular basis of RTT neuropathogenesis remains unclear. Using multiple cDNA microarray technologies, subtractive hybridization, and conventional biochemistry, we generated comprehensive gene expression profiles of postmortem brain tissue from RTT patients and matched controls. Many glial transcripts involved in known neuropathological mechanisms were found to have increased expression in RTT brain, while decreases were observed in the expression of multiple neuron-specific mRNAs. Dramatic and consistent decreases in transcripts encoding presynaptic markers indicated a specific deficit in presynaptic development. Employing multiple clustering algorithms, it was possible to accurately segregate RTT from control brain tissue samples based solely on gene expression profile. Although previously achieved in cancers, our results constitute the first report of human disease classification using gene expression profiling in a complex tissue source such as brain.

References (99)

  • I. Meloni et al.

    A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males

    Am. J. Hum. Genet.

    (2000)
  • K. Mirnics et al.

    Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

    Neuron

    (2000)
  • X. Nan et al.

    MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin

    Cell

    (1997)
  • H.H. Ng et al.

    DNA methylation and chromatin modification

    Curr. Opin. Genet. Dev.

    (1999)
  • A. Oldfors et al.

    Rett syndrome: Spinal cord neuropathology

    Pediatr. Neurol.

    (1988)
  • A. Oldfors et al.

    Rett syndrome: Cerebellar pathology

    Pediatr. Neurol.

    (1990)
  • A. Orrico et al.

    MECP2 mutation in male patients with non-specific X-linked mental retardation

    FEBS Lett.

    (2000)
  • I.B. Van den Veyver et al.

    Methyl-CpG-binding protein 2 mutations in Rett syndrome

    Curr. Opin. Genet. Dev.

    (2000)
  • M. Wan et al.

    Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots

    Am. J. Hum. Genet.

    (1999)
  • K. Wang et al.

    Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray

    Gene

    (1999)
  • Y. Zhou et al.

    A dynamically regulated 14-3-3, Slob, and Slowpoke potassium channel complex in Drosophila presynaptic nerve terminals

    Neuron

    (1999)
  • A. Alizadeh et al.

    The lymphochip: A specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes

    Cold Spring Harb. Symp. Quant. Biol.

    (1999)
  • N. Allaman-Pillet et al.

    Methylation status of CpG sites and methyl-CpG binding proteins are involved in the promoter regulation of the mouse Xist gene

    Gene Exp.

    (1998)
  • K. Amano et al.

    Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome

    J. Hum. Genet.

    (2000)
  • R.E. Amir et al.

    Rett syndrome: Methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations

    Am. J. Med. Genet. (Semin. Med. Genet.)

    (2000)
  • R.E. Amir et al.

    Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

    Nat. Genet.

    (1999)
  • R.E. Amir et al.

    Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes

    Ann. Neurol.

    (2000)
  • D.D. Armstrong

    Review of Rett syndrome

    J. Neuropathol. Exp. Neurol.

    (1997)
  • M.L. Bauman et al.

    Microscopic observations of the brain in Rett syndrome

    Neuropediatrics

    (1995)
  • M.L. Bauman et al.

    Pervasive neuroanatomic abnormalities of the brain in three cases of Rett's syndrome

    Neurology

    (1995)
  • P.V. Belichenko et al.

    Morphological study of neocortical areas in Rett syndrome

    Acta Neuropathol.

    (1997)
  • P.V. Belichenko et al.

    Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents

    Neuroreport

    (1994)
  • T. Bienvenu et al.

    MECP2 mutations account for most cases of typical forms of Rett syndrome

    Hum. Mol. Genet.

    (2000)
  • M. Bittner et al.

    Molecular classification of cutaneous malignant melanoma by gene expression profiling

    Nature

    (2000)
  • C. Bouton et al.

    Dragon: database referencing of array genes online

    Bioinformatics

    (2000)
  • E.E. Cameron et al.

    Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

    Nat. Genet.

    (1999)
  • J.P. Cheadle et al.

    Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and location

    Hum. Mol. Genet.

    (2000)
  • R.Z. Chen et al.

    Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice

    Nat. Genet.

    (2001)
  • C. Colantuoni et al.

    High throughput analysis of gene expression in the human brain

    J. Neurosci. Res.

    (2000)
  • M. Constancia et al.

    Imprinting mechanisms

    Genome Res.

    (1998)
  • P. Couvert et al.

    MECP2 is highly mutated in X-linked mental retardation

    Hum. Mol. Genet.

    (2001)
  • C. De Bona et al.

    Preserved speech variant is allelic of classic Rett syndrome

    Eur. J. Hum. Genet.

    (2000)
  • J. DeRisi et al.

    Use of a cDNA microarray to analyse gene expression patterns in human cancer

    Nat. Genet.

    (1996)
  • J. Dragich et al.

    Rett syndrome: A surprising result of mutation in MECP2

    Hum. Mol. Genet.

    (2000)
  • J. Elek et al.

    Microarray-based expression profiling in prostate tumors

    In Vivo

    (2000)
  • L.F. Eng et al.

    Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers

    J. Neurosci. Res.

    (1998)
  • J.E. Goldman et al.

    Rosenthal fibers contain ubiquitinated alpha B-crystallin

    Am. J. Pathol.

    (1991)
  • T.R. Golub et al.

    Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

    Science

    (1999)
  • J. Guy et al.

    A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome

    Nat. Genet.

    (2001)
  • Cited by (0)

    1

    Current address: Corning Microarray Technologies, Corning, New York 14831.

    View full text